| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $7,702,597 | 28 | 100 |
| SIEGAL JONATHAN | Principal Accounting Officer | 0 | $0 | 4 | $324,745 | $-324,745 |
| Mara Joseph Anthony Jr | Chief Financial Officer | 0 | $0 | 2 | $426,250 | $-426,250 |
| Hagen Heidi | director | 0 | $0 | 1 | $486,150 | $-486,150 |
| Hopper Jonathan Mark | Chief Medical Officer | 0 | $0 | 4 | $564,304 | $-564,304 |
| Wotton Paul K | director | 0 | $0 | 4 | $761,725 | $-761,725 |
| MCLAUGHLIN KEVIN F | director | 0 | $0 | 4 | $1.05M | $-1.05M |
| Flynn Sean C. | Chief Legal Officer | 0 | $0 | 3 | $2.04M | $-2.04M |
| Halpin Michael | Chief Operating Officer | 0 | $0 | 6 | $2.04M | $-2.04M |
Vericel Corporation operates as a biopharmaceutical firm that has reached the commercialization phase, specializing in the research, development, production, and distribution of cell-based treatments. Its primary therapeutic areas are sports medicine and critical burn care across the United States. The company's product lineup includes MACI, an autologous cellularized scaffold employed for mending symptomatic, full-thickness cartilage damage in the knee, and Epicel, a permanent skin replacement designated as a humanitarian use device for …
Over the last 12 months, insiders at Vericel Corporation have bought $0 and sold $7.7M worth of Vericel Corporation stock.
On average, over the past 5 years, insiders at Vericel Corporation have bought $0 and sold $9.81M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,780 shares for transaction amount of $20,592 was made by Rubino Alan L (director) on 2018‑03‑16.
| 2026-08-12 | Sale | MCLAUGHLIN KEVIN F | director | 7,000 0.0136% | $44.53 | $311,710 | -9.49% | |
| 2026-08-03 | Sale | Halpin Michael | Chief Operating Officer | 10,000 0.02% | $46.84 | $468,400 | -11.81% | |
| 2026-07-30 | Sale | SIEGAL JONATHAN | Principal Accounting Officer | 500 0.001% | $48.90 | $24,450 | -14.68% | |
| 2026-06-26 | Sale | Hopper Jonathan Mark | Chief Medical Officer | 5,000 0.0095% | $45.00 | $225,000 | -8.35% | |
| 2026-06-26 | Sale | Mara Joseph Anthony Jr | Chief Financial Officer | 5,000 0.0095% | $44.75 | $223,750 | -8.35% | |
| 2026-06-26 | Sale | Flynn Sean C. | Chief Legal Officer | 15,000 0.029% | $45.64 | $684,600 | -8.35% | |
| 2026-06-26 | Sale | SIEGAL JONATHAN | Principal Accounting Officer | 2,500 0.0048% | $44.90 | $112,250 | -8.35% | |
| 2026-06-18 | Sale | Halpin Michael | Chief Operating Officer | 10,000 0.0197% | $40.24 | $402,400 | +5.49% | |
| 2026-06-18 | Sale | Flynn Sean C. | Chief Legal Officer | 15,000 0.0295% | $40.21 | $603,150 | +5.49% | |
| 2026-06-02 | Sale | Hopper Jonathan Mark | Chief Medical Officer | 4,375 0.0087% | $35.00 | $153,125 | +19.22% | |
| 2026-05-13 | Sale | MCLAUGHLIN KEVIN F | director | 7,000 0.0137% | $32.83 | $229,775 | +23.68% | |
| 2026-05-11 | Sale | Wotton Paul K | director | 10,000 0.0195% | $32.74 | $327,425 | +23.31% | |
| 2026-05-11 | Sale | Wotton Paul K | director | 7,500 0.0146% | $32.64 | $244,800 | +23.31% | |
| 2026-05-07 | Sale | Mara Joseph Anthony Jr | Chief Financial Officer | 5,000 0.0113% | $40.50 | $202,500 | +15.41% | |
| 2026-05-07 | Sale | SIEGAL JONATHAN | Principal Accounting Officer | 1,422 0.0032% | $40.50 | $57,591 | +15.41% | |
| 2026-05-06 | Sale | SIEGAL JONATHAN | Principal Accounting Officer | 3,433 0.007% | $38.00 | $130,454 | +10.14% | |
| 2026-04-02 | Sale | Hopper Jonathan Mark | Chief Medical Officer | 3,472 0.0074% | $35.00 | $121,520 | +17.75% | |
| 2026-03-23 | Sale | Hagen Heidi | director | 15,000 0.0295% | $32.41 | $486,150 | +23.62% | |
| 2026-03-02 | Sale | Halpin Michael | Chief Operating Officer | 10,305 0.0202% | $35.30 | $363,767 | +12.33% | |
| 2026-03-02 | Sale | Flynn Sean C. | Chief Legal Officer | 21,421 0.0418% | $35.18 | $753,530 | +12.33% |
| ARMSTRONG R DOUGLAS PHD | Chairman and CEO | 573763 1.1205% | $23.58M | 2 | 5 | <0.0001% |
| Colangelo Dominick | President and CEO | 260354 0.5084% | $10.7M | 1 | 41 | +18.13% |
| MAYLEBEN TIMOTHY M | President and CEO | 133000 0.2597% | $5.46M | 9 | 0 | +21.76% |
| MICHEL GERARD J | CFO and VP, Corp. Development | 123182 0.2406% | $5.06M | 1 | 12 | +18.13% |
| CRESSWELL RONALD M | director | 40000 0.0781% | $1.64M | 2 | 0 | +3.5% |
| Brennan Gerald JR | VP Admin. and Finance, CFO | 30000 0.0586% | $1.23M | 2 | 0 | <0.0001% |
| SUDOVAR STEPHEN | director | 26900 0.0525% | $1.11M | 2 | 0 | <0.0001% |
| DUNBAR GEORGE W JR | director | 12750 0.0249% | $523,897.50 | 3 | 0 | <0.0001% |
| Orlando Daniel | Chief Operating Officer | 12518 0.0244% | $514,364.62 | 1 | 1 | +18.13% |
| SIMS NELSON M | director | 10000 0.0195% | $410,900.00 | 1 | 0 | <0.0001% |
| FINGERLE LINDA M | 6927 0.0135% | $284,630.43 | 18 | 1 | +41.69% | |
| CAMPBELL MARY L | director | 1633 0.0032% | $67,099.97 | 6 | 0 | +26.72% |
| Rubino Alan L | director | 850 0.0017% | $34,926.50 | 1 | 0 | +14.22% |
| Durbin Scott | CFO | 0 0% | $0 | 4 | 1 | +21.07% |
$607,395,062 | 99 | 4.23% | $1.88B | |
$21,345,882 | 83 | 94.45% | $2.19B | |
$47,419,530 | 58 | 17.20% | $1.96B | |
Vericel Corporation (VCEL) | $1,376,668 | 53 | 18.46% | $2.1B |
$108,353,116 | 49 | 15.41% | $2.17B |
| Increased Positions | 164 | +63.08% | 7M | +12.21% |
| Decreased Positions | 112 | -43.08% | 6M | -10.76% |
| New Positions | 58 | New | 2M | New |
| Sold Out Positions | 31 | Sold Out | 2M | Sold Out |
| Total Postitions | 312 | +20% | 54M | +1.46% |
| Blackrock, Inc. | $269,540.00 | 14.84% | 7.57M | -9,347 | -0.12% | 2025-09-30 |
| Vanguard Group Inc | $125,192.00 | 6.89% | 3.52M | -47,833 | -1.34% | 2025-09-30 |
| State Street Corp | $99,966.00 | 5.5% | 2.81M | +371,845 | +15.27% | 2025-09-30 |
| William Blair Investment Management, Llc | $78,731.00 | 4.34% | 2.21M | +1M | +90.26% | 2025-09-30 |
| Conestoga Capital Advisors, Llc | $77,462.00 | 4.26% | 2.18M | -288,306 | -11.7% | 2025-09-30 |
| Fmr Llc | $71,857.00 | 3.96% | 2.02M | -456,301 | -18.44% | 2025-09-30 |
| Brown Capital Management Llc | $69,475.00 | 3.83% | 1.95M | -861,020 | -30.62% | 2025-09-30 |
| Geneva Capital Management Llc | $69,308.00 | 3.82% | 1.95M | +161,378 | +9.04% | 2025-09-30 |
| Congress Asset Management Co | $53,223.00 | 2.93% | 1.49M | -247,717 | -14.22% | 2025-09-30 |
| Gw&K Investment Management, Llc | $45,943.00 | 2.53% | 1.29M | -124,377 | -8.79% | 2025-09-30 |